Omeros Corporation (OMER)
NASDAQ: OMER · Real-Time Price · USD
3.610
-0.260 (-6.72%)
At close: Aug 1, 2025, 4:00 PM
3.560
-0.050 (-1.39%)
After-hours: Aug 1, 2025, 4:53 PM EDT
Omeros Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
202
Market Cap
242.33M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
OMER News
- 8 days ago - Omeros Corporation Announces Pricing of $22 Million Registered Direct Offering - Business Wire
- 5 weeks ago - Omeros Submits Narsoplimab Marketing Authorization Application to the European Medicines Agency for the Treatment of TA-TMA - Business Wire
- 5 weeks ago - Omeros Announces Webcast Details for Annual Meeting of Shareholders - Business Wire
- 7 weeks ago - Omeros Analyst Sees $1 Billion Potential For Narsoplimab Before FDA Decision - Benzinga
- 2 months ago - Omeros: On The Brink As It Awaits Its Fall PDUFA For A Potential Blockbuster - Seeking Alpha
- 2 months ago - Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter - Benzinga
- 2 months ago - Omeros Corporation (OMER) Q1 2025 Earnings Conference Call Transcript - Seeking Alpha
- 2 months ago - Omeros Corporation Reports First Quarter 2025 Financial Results - Business Wire